KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Revenue (2016 - 2025)

Historic Revenue for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $1.4 billion.

  • BeOne Medicines' Revenue rose 4100.29% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 4992.31%. This contributed to the annual value of $3.8 billion for FY2024, which is 5496.48% up from last year.
  • Latest data reveals that BeOne Medicines reported Revenue of $1.4 billion as of Q3 2025, which was up 4100.29% from $1.3 billion recorded in Q2 2025.
  • BeOne Medicines' 5-year Revenue high stood at $1.4 billion for Q3 2025, and its period low was $150.0 million during Q2 2021.
  • Moreover, its 5-year median value for Revenue was $605.9 million (2021), whereas its average is $668.7 million.
  • As far as peak fluctuations go, BeOne Medicines' Revenue skyrocketed by 106381.8% in 2021, and later plummeted by 4939.1% in 2022.
  • Over the past 5 years, BeOne Medicines' Revenue (Quarter) stood at $214.0 million in 2021, then soared by 77.63% to $380.1 million in 2022, then soared by 66.91% to $634.4 million in 2023, then skyrocketed by 77.78% to $1.1 billion in 2024, then increased by 25.22% to $1.4 billion in 2025.
  • Its Revenue stands at $1.4 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.1 billion for Q1 2025.